Xopenex and Respiratory disorder - a phase IV clinical study of FDA data

Summary:

Respiratory disorder is reported as a side effect among people who take Xopenex (levalbuterol hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Singulair, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Respiratory disorder when taking Xopenex. It is created by eHealthMe based on reports of 13,420 people who have side effects when taking Xopenex from the FDA, and is updated regularly.

What is Xopenex?

Xopenex has active ingredients of levalbuterol hydrochloride. It is often used in asthma. eHealthMe is studying from 13,816 Xopenex users. Check the latest studies of Xopenex.

What is Respiratory disorder?

Respiratory disorder (respiratory disease) is found to be associated with 1,535 drugs and 1,584 conditions by eHealthMe. Check the latest studies of Respiratory disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

13,420 people reported to have side effects when taking Xopenex.
Among them, 91 people (0.68%) have Respiratory disorder.

Could Xopenex cause Respiratory disorder?

Among these 91 people:

How long have people been on Xopenex when they have Respiratory disorder? *

What is the gender of people who have Respiratory disorder when taking Xopenex? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Respiratory disorder when taking Xopenex? *

What are other drugs people take besides Xopenex? *

What are other side effects people have besides Respiratory disorder? *

Dyspnea (difficult or laboured breathing): 33 people, 36.26%
Fatigue (feeling of tiredness): 26 people, 28.57%
Pneumonia: 18 people, 19.78%
Headache (pain in head): 18 people, 19.78%
Weakness: 17 people, 18.68%
Insomnia (sleeplessness): 15 people, 16.48%
High Blood Pressure: 14 people, 15.38%
Feeling Abnormal: 12 people, 13.19%
Malaise (a feeling of general discomfort or uneasiness): 12 people, 13.19%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 12 people, 13.19%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 18 people, 19.78%
Stress And Anxiety: 9 people, 9.89%
Insomnia (sleeplessness): 7 people, 7.69%
Indigestion: 7 people, 7.69%
Pain: 6 people, 6.59%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 6.59%
Constipation: 5 people, 5.49%
Primary Immunodeficiency Syndrome: 4 people, 4.40%
Sleep Disorder: 4 people, 4.40%
High Blood Pressure: 4 people, 4.40%

* Approximation only. Some reports may have incomplete information.

Do you take Xopenex and have Respiratory disorder?

- Check whether Respiratory disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xopenex:

Xopenex (13,816 reports)

Browse all side effects of Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Respiratory disorder:

Respiratory disorder (1,535 drugs)

Browse all the conditions that are associated with Respiratory disorder:

Respiratory disorder (1,584 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levalbuterol hydrochloride (the active ingredients of Xopenex) and Xopenex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.